THERE’S NO BETTER PREVENTION THAN SHARING THE KNOWLEDGE FASTER THAN THEY SHARE THEIR PROPAGANDA!
The original title of this article was URGENT! DEBUNKING THE NEXT ENGINEERED PANDEMIC: NIPAH VIRUS. I expanded the scope because in the meantime I learned they are ramping up propaganda for all three. These viruses have more things in common, as you will find out below.
UPDATE 6: NOVEMBER 9, 2021:
To further develop the ChAd3 Ebola and Marburg vaccines, Sabin has entered into a Research Collaboration Agreement with the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases. The Sabin Vaccine Institute, a non-profit organization founded in 1993, is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Sabin received more than $110 million for vaccine R&D programs from public and philanthropic funding sources, including the Bill & Melinda Gates Foundation, European Commission, Dutch Ministry of Foreign Affairs, Global Health Innovative Technology Fund and the Michelson Medical Research Foundation.
Washington DC, Oct. 21, 2021 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute (Sabin) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, has exercised the third contract option, valued at $34.5 million, under the 2019 contract to advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials.
In September 2019, BARDA awarded Sabin a development contract, valued up to $128 million, and has already provided funding of $40.5 million. This third contract option will enable continued nonclinical efficacy and safety studies, Phase 2 clinical trials in Africa, and vaccine manufacturing processes to ensure quality and safety.
In August, a case of Marburg disease was confirmed in the West African country of Guinea where the Ministry of Health officially declared an outbreak of Marburg.1 This recent case, as well as Marburg’s history of outbreaks and their potential for future devastating outbreaks, demonstrates that preventative measures are overdue to protect civilian populations, military personnel, first responders, health care workers and laboratory workers, both in the United States and abroad, against these emerging infectious diseases.
Ebola Sudan and Marburg viruses are closely related to Ebola Zaire virus, which has caused more than 2,200 deaths since 2018, leading the World Health Organization (WHO) to declare it a Public Health Emergency of International Concern. Like Ebola Zaire, Ebola Sudan and Marburg are among the world’s deadliest viruses, causing hemorrhagic fever with subsequent death in an average of 50 percent of cases.2,3
“Even as the world struggles with the COVID-19 pandemic, disease caused by Ebola Sudan and Marburg viruses continue to be a serious threat, as we have seen with the recent outbreak of Marburg in Guinea. We are grateful for BARDA’s continued support of Sabin’s efforts to advance vaccines against these deadly viruses,” said Sabin Chief Executive Officer Amy Finan. “We also thank our partners at the Vaccine Research Center of the NIH National Institute of Allergy and Infectious Diseases for their continued collaboration, and GSK for their earlier work on the candidates.”
The two candidate vaccines, based on GSK’s proprietary ChAd3 platform, were exclusively licensed to the Sabin Vaccine Institute from GSK in 2019.
This project has been funded in whole or in part with federal funds from the U.S. Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under contract number 75A50119C00055.
This above is the official Sabin Inst. press release, this below isn’t:
November 4, 2021 – The U.S. CDC published a Level Three Travel Advisory for the recent Ebola outbreak in the Beni Health Zone of the Democratic Republic of the Congo.
November 3, 2021 – The U.S. CDC vaccine advisory committee reviewed previous recommendation preexposure vaccination with Ervebo for adults aged ≥18 years in the U.S. population who are at highest risk for potential occupational exposure to Ebola virus species Zaire ebolavirus because they are: responding to an outbreak of Ebola Virus Disease (EVD), or work as health care personnel at federally designated Ebola treatment centers in the U.S., or work as laboratorians or other staff at biosafety level 4 facilities in the U.S.
November 2, 2021 – The WHO reported additional cases and deaths confirmed in the Ebola virus disease outbreak in the Democratic Republic of the Congo with two new health areas affected. A total of 394 people (67 primary care providers including nine high-risk contacts, nine contacts of contacts, and 49 probable contacts) have been vaccinated including 182 contacts of contacts, 125 probable contacts, and 87 high-risk contacts.
October 29, 2021 – A Research Article – Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomized, placebo-controlled Phase II clinical trial in Africa – was published by the journal PLOS Medicine. Conclusion – The Ad26.ZEBOV and MVA-BN-Filo combo vaccination were well tolerated and immunogenic in healthy and HIV-infected African adults. Increasing the interval between vaccinations from 28 to 56 days improved the magnitude of humoral immune responses. Antibody levels persisted to at least 1 year, and an Ad26.ZEBOV booster vaccination demonstrated the presence of vaccination-induced immune memory. These data supported the approval by the European Union for prophylaxis against EBOV disease in adults and children ≥1 year of age.
October 27, 2021 – IAVI announced an award of up to US$126 million from the Biomedical Advanced Research and Development Authority to develop two recombinant vesicular stomatitis virus (rVSV)-vectored filovirus vaccine candidates. This award supports preclinical activities and includes options for clinical development up to and inclusive of a Phase II clinical trial of IAVI’s rVSV Sudan ebolavirus vaccine candidate (rVSVΔG-SUDV-GP). Optional work that would continue the development of IAVI’s Marburg virus vaccine candidate (rVSVΔG-MARV-GP) that is currently supported by the Defense Threat Reduction Agency of the U.S. Department of Defense could be funded at a later date.
“Vectored” means, most likely, mRNA or some other genetic / nanotech targeting technology.
October 20, 2021 – The WHO African Region reported 5 Ebola cases, and over 27,000 travelers have been screened in the DRC. Furthermore, over 116 people have been vaccinated.
October 17, 2021 – Africa News reported Ebola vaccinations started in Beni, DRC, after at least two people died due to the virus in October 2021. The WHO African Region Tweeted DRC Situation Report (17/10/21) 5 confirmed cases, three deaths, 369 contacts identified, and 308 contacts monitored.
October 13, 2021 – Democratic Republic of the Congo (DRC) health officials confirmed an Ebola vaccination campaign had launched in the North Kivu province where one confirmed Ebola case, plus three related suspected deaths, were recently reported. About 1,000 doses of the rVSV-ZEBOV Ebola vaccine and other medical supplies were delivered from the capital Kinshasa to Goma city in North Kivu. The DRC has more than 12,000 vaccine doses in Kinshasa that can be deployed if necessary.
October 10, 2021 – The WHO reported additional Ebola cases related to the recent DRC case of a 3-year-old boy. A cluster of three deaths (two children and their father) who were neighbors of the case. These three patients died on 14, 19, and 29 September 2021 after developing symptoms consistent with Ebola. However, none were tested for the virus. As of October 9th, a total of 148 contacts have been identified and are under follow-up by the local response team.
October 8, 2021 – A case of Ebola has been confirmed in the eastern Democratic Republic of the Congo, five months after the end of the most recent Ebola outbreak there. The child died on October 6th. It was not immediately known if the Ebola case was related to the 2018-20 outbreak that killed more than 2,200 people in eastern Congo or the flare-up that killed six people in 2021.
September 13, 2021 – A new study based in Sierra Leone concluded the Ebola vaccine regimen from Janssen – J&J. It was found well tolerated with no safety concerns in children aged 1–17 years and induced robust humoral immune responses, suggesting the suitability of this regimen for Ebola virus disease prevention in children.
August 31, 2021 – The government of Cote d’Ivoire has informed the WHO that a second laboratory has tested samples from a patient suspected of having Ebola and has found no evidence of the virus. Around a dozen WHO experts were mobilized to support the country’s efforts, and 5,000 Ebola vaccine doses which WHO had helped Guinea procure were sent from Guinea to Cote d’Ivoire.
August 23, 2021 – The WHO African region reported Ebola booster dose vaccinations in Sierra Leone following administration of the prime dose of the Johnson & Johnson Ebola vaccine in May 2021. Frontline health workers, practitioners of traditional medicines or traditional healers, and commercial motorbike riders who received the first dose are now given their second jab to maximize their protection against the disease.
August 17, 2021 – The WHO confirmed Cote d’Ivoire deployed 2,000 vaccine doses from Merck and around 3,000 vaccine doses manufactured by Johnson & Johnson – Janssen.
August 14, 2021 – The WHO Africa reported the Ministry of Health of Cote d’Ivoire today confirmed the country’s first case of Ebola since 1994. This came after the Institut Pasteur in Cote d’Ivoire confirmed the Ebola Virus Disease in samples collected from a patient hospitalized in Abidjan’s commercial capital after arriving from Guinea.
August 9, 2021 – The WHO confirmed ‘Marburg virus disease (MVD) is a highly virulent, epidemic-prone disease associated with high case fatality rates (CFR 24-90%). In the early course of the disease, the clinical diagnosis of MVD is difficult to distinguish from other tropical febrile illnesses because of the similarities in the clinical symptoms. Differential diagnoses to be excluded include Ebola virus disease, as well as malaria, typhoid fever, leptospirosis, rickettsial infection, and plague.’
June 15, 2021 – The Southwest National Primate Research Center at Texas Biomedical Research Institute (Texas Biomed) has been awarded more than $37 million from the U.S. National Institutes of Health to continue operations into 2026. The P51 grant, given by the NIH Office of Research Infrastructure Programs, provides essential funding to house and care for nearly 2,500 non-human primates that are part of life-science research programs at Texas Biomed and partners around the globe.
June 4, 2021 – Johnson & Johnson welcomed a new recommendation by the Strategic Advisory Group of Experts on Immunization for the WHO that supports the use of the Johnson & Johnson Ebola vaccine regimen both during outbreaks for individuals at some risk of Ebola exposure and preventively, in the absence of an outbreak, for national and international first responders in neighboring areas or countries where an outbreak might spread.
April 10, 2021 – The government of Sierra Leone and the WHO announced Johnson & Johnson had donated about 4,500 Zabdeno and Mvabea Ebola vaccines to Sierra Leone to help prevent any Ebola outbreak. The last Ebola outbreak in Sierra Leone was in 2016.
March 25, 2021 – Ohio Gov. Mike DeWine revealed health officials are monitoring 44 people who have returned from areas of Africa with active outbreaks of Ebola.
March 25, 2021 – Oregon public health officials announced they are monitoring four people who recently visited the West African countries of Guinea and the Democratic Republic of the Congo. Regions in each of these countries are currently experiencing outbreaks of Ebola virus disease. The Oregon Health Authority and local public health departments have been in contact with these individuals, considered “persons under monitoring” since they arrived in the state earlier in March 2021.
March 23, 2021 – The WHO African Region Tweeted Guinea Ebola outbreak Situation Report (22/03/21) 18 cases, nine deaths, 78 contacts, 82% monitored. And 3,905 people have been vaccinated.
March 13, 2021 – After a request from the Guinean authorities, Russia is considering supplying a domestic vaccine against the Ebola virus to the African country, reported TASS.
May 13, 2020 – BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines
The Sabin Vaccine Institute (Sabin) and its partner ReiThera Srl today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, has exercised the first two options, valued at $20 million, under the 2019 contract to advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials. In September 2019, BARDA awarded Sabin a development contract, valued at $128 million, and provided the initial funding award of $20.5 million. This second $20 million award will enable the manufacture and release of clinical vaccine material developed by ReiThera, a specialist in the development and cGMP manufacture of adenoviral vector vaccines. The funding will also support non-clinical studies to evaluate efficacy and immune response.
UPDATE 5: NOVEMBER 7, 2021: MARBURG GOES VIRAL ON INTERNET ONLY, YET. I’m happy awareness increases, it’s crucial. I’ve addressed this virus below, but not many had the patience to go through all text, and I kind of understand them, but there’s no easier way than reading. Here’s another angle to keep in sight when computing all this info:
UPDATE 4: OCTOBER 19 2021: THE FEARPORN CAMPAIGN TAKES SPEED AS IF THEY ARE TO RELEASE THIS SOON. IF YOU FALL FOR THEIR BRAINWASH, THEY HAVE NO REASON TO STOP.
And they’re still not running out of stupid ideas we can see through:
UPDATE 3: OCTOBER 17 2021:
Guess who has a vaccine in works for it
Oh, look who pushes the fear! Exactly who I would’ve expected:
Later update: In the meantime I’ve learned that Marburg (an Ebola relative) and Xinjiang fever, a Chinese relative of the Yellow Fever virus, are also top candidates, and that goes in line with the Fauci e-mails I highlighted below. I will be back with more details shortly. Almost certainly it will be some form of hemorrhagic fever, most likely to cover for injections side-effects on the blood stream.
One month later, they’re starting to catch up and it’s still not too late to un-play it if this goes BOOM NOW!
By the end of last century, The Military has abandoned you and has joined Pharmafia and the super-rich elites in a plan to govern you with bioweapons and psy-ops. As I’ve said many times, Big Pharma and Big Tech are long gone, The Military BioTech Complex has been running the show for quite a while. This is just a chapter from that book, more to come if we get some love.
Canadian lab’s shipment of Ebola, Henipah viruses to China raises questions
Henipah and Nipah are interchangeable
Scientists at the National Microbiology Lab sent live Ebola and Henipah viruses to Beijing on an Air Canada flight March 31, and while the Public Health Agency of Canada says all federal policies were followed, there are questions about whether that shipment is part of an ongoing RCMP investigation.
Ebola and Henipah are Level 4 pathogens, meaning they’re some of the deadliest viruses in the world. They must be contained in a lab with the highest level of biosafety control, such as the one in Winnipeg.
Two months after that shipment, on May 24, the Public Health Agency of Canada (PHAC) referred an “administrative matter” to RCMP that resulted in the removal of two Chinese research scientists — Xiangguo Qiu and Keding Cheng — and several international students on July 5.
Both agencies have said repeatedly that public safety has not been at risk.
PHAC will not confirm if the March 31 shipment is part of the RCMP investigation.
Several sources, who have asked to remain anonymous because they fear for their jobs, say the pathogens may have been shipped to the Chinese Academy of Sciences in a way that circumvented the lab’s operating procedures, and without a document protecting Canada’s intellectual property rights.
Researchers working at the National Microbiology Lab on cutting-edge, high-containment research are not allowed to send anything to other countries or labs without the intellectual property office negotiating and having a material transfer agreement in place, in case the material sent leads to a notable discovery.
A PHAC spokesperson did not confirm if this shipment included such an agreement.
However, Eric Morrissette said it’s “routine” for the lab to share samples of pathogens and toxins with partners in other countries to advance scientific work worldwide.
“All transfers of Risk Group 4 samples follow strict transportation requirements and are authorized by senior officials at the lab and the NML tracks and keeps electronic records of all shipments of samples in accordance with the HPTA. Agreements for the transfer of materials are determined on a case-by-case basis,” Morrisette wrote in an email statement.
“On the specific shipments to China earlier this year, we can confirm that we have all records pertaining to the shipment, and that all protocols were followed as directed by the above Acts and Standards.”
Xiangguo Qiu is head of the National Microbiology Lab’s Vaccine Development and Antiviral Therapies section in the Special Pathogens Program. She is responsible for the lab that works with Ebola. Her husband, Keding Cheng, is also a PHAC biologist.
After their security clearance was revoked and they were escorted from the lab, the University of Manitoba also cut ties with them and re-assigned Qiu’s graduate students, pending the RCMP investigation. No charges have been laid.
One question raised by this case is that of intellectual property protection, says Leah West, who practises, studies and publishes in the field of national security law and lectures at the Norman Paterson School of International Affairs.
“If China was leveraging these scientists in Canada to gain access to a potentially valuable pathogen or to elements of a virus without having to license the patent … it makes sense with the idea of China trying to gain access to valuable IP without paying for it,” she said.
West accepts PHAC’s assertion that public safety is not an issue, even though the viruses were transported on a commercial Air Canada flight.
However, she says the fact the RCMP is involved means there’s a legitimate concern.
“You don’t send a policy breach, a bureaucratic policy breach, to the RCMP to investigate unless you believe that that policy breach has resulted in a criminal offence or could have resulted in a criminal offence. So what is the criminal offence potentially here?” West said.
She said she hopes the lab and Health Canada are also doing an internal investigation.
“I think there will need to be an inquiry into the scientists to potentially see whether or not they were compromised or any elements of their work were compromised and that China gained illegal or improper access to Canadian intellectual property … to see what China may have gained access to without knowledge, prior to this incident,” West says.
Don’t ‘jump into any conclusions too quickly’
However, the deputy director of the University of Alberta’s China Institute is urging caution when it comes to making assumptions.
Jia Wang doesn’t dispute China has been involved in the past in espionage and intellectual property theft, but she says that country is making big investments in developing STEM (science, technology, engineering and mathematics) scholars and then putting that into innovation.
China has its own reasons to protect intellectual property because many new ideas are coming from there, Wang says.
She’s waiting to see what comes of the RCMP investigation of the lab in Winnipeg.
“As China observers, we’d like to perhaps gently remind people not to jump into any conclusions too quickly,” she said.
“It will be good to get to the bottom of this and see what might have gone wrong and what was the oversight and how can the procedures be improved or people involved can be reminded of how to adhere to the policies better.”
The shipment of the viruses took place at a time when relations between Canada and China have been strained over the arrest of a Huawei executive, at the request of the United States.
In retaliation, China has detained two Canadians and is boycotting Canadian canola and pork.
Because of the strained relationship between the two countries, and this case at the lab, Chinese-Canadian researchers and academics are starting to worry they may be singled out and targeted, Wang said.
“Certain assumptions are made or their loyalty to Canada is questioned in any way. And as multicultural as we are in Canada, we don’t want to see that.” – CBC, 2019
On December 19, 2019, the U.S. Food and Drug Administration announced the approval of Ervebo to prevent EVD caused by Zaire ebolavirus in individuals 18 years of age and older. This report, published by the U.S. CDC on January 8, 2021, summarizes the Advisory Committee on Immunization Practices (ACIP) recommendations for using the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the USA.
On July 1, 2020, the European Medicines Agency granted Johnson & Johnson Janssen’s Zabdeno and Mvabea Ebola vaccine therapy, a prime-boost vaccination approach for preventing infectious diseases. Janssen’s Ebola vaccine regimen is specifically designed to induce long-term immunity against the Ebola virus in adults and children aged one year and above.
CanSino Biologics’s Ad5-EBOV Ebola vaccine received approval in China in October 2017. Ad5-EBOV is an adenovirus type 5 vector-based Ebola virus disease vaccine that protects against Ebola by relying on the recombinant replication-defective human adenovirus type-5 vector immune response. In addition, Ad5-EBOV is manufactured as a lyophilized powder, highly stable, and does not require storage at ultra-low temperatures. This feature renders it viable for use in resource-limited tropical areas.
The WHO published the revised Ebola Vaccine FAQ on January 11, 2020.
Henipaviruses belong to the family of paramyxoviruses. Two species have been identified to be zoonotic, causing disease in animals. These are the Hendra virus (HeV) and the Nipah virus (NiV). They produce severe and often fatal illness in humans and horses.
THAT IS TO SAY ‘NIPAH’, ‘HENIPAH’ AND ‘HENIPAVIRUS’ ARE INTERCHANGEABLE HERE
Samples from early Wuhan COVID-19 patients show the presence of genetically modified Henipah virus, an American scientist has found.
Henipah was one of the two types of viruses sent to China by Chinese-born scientists from a Canadian laboratory at the centre of a controversy over the firing of the scientists and collaboration with Chinese military researchers. It is not clear whether the virus found in the Chinese samples is related to the samples sent by the Canadian lab, which were shipped in late March 2019.
The finding was confirmed for The Epoch Times by another qualified scientist.
The evidence was first found by Dr. Steven Quay, a Seattle-based physician-scientist and former faculty member at the Stanford University School of Medicine, who looked at early COVID-19 samples uploaded by scientists at the Wuhan Institute of Virology (WIV) shortly after China informed the World Health Organization about the SARS-CoV-2 outbreak.
The samples from the patients, who reportedly were found to have the “unknown pneumonia” in December 2019, were uploaded to the genetic sequence database, GenBank, on the website of the U.S. National Institute of Health (NIH).
Quay says that while other scientists around the world were mostly interested in examining the genome of SARS-CoV-2 in the samples uploaded by the WIV scientists, he wanted to see what else was in the samples collected from the patients.
So he collaborated with a few other scientists to analyze sequences from the samples.
“We started fishing inside for weird things,” Quay told The Epoch Times.
What they found, he says, are the results of what could likely be contamination from different experiments in the lab making their way into the samples, as well as evidence of Henipah virus.
“We found genetic manipulation of the Nipah virus, which is more lethal than Ebola.” Nipah is a type of Henipah virus.
The Epoch Times asked Joe Wang, PhD, who formerly spearheaded a vaccine development program for SARS in Canada with one of the world’s leading pharmaceutical companies, to verify the finding. Wang is currently the president of NTD Television Canada, the sister company of The Epoch Times in Canada.
After examining the evidence, Wang said he was able to replicate Quay’s findings on the Henipah virus. He explains that the genetic manipulation of the virus was likely for the purposes of vaccine development.
The firing of Chinese-born scientist Xiangguo Qiu and her husband, Keding Cheng, from the National Microbiology laboratory (NML) in Winnipeg has been the subject of much controversy in Canada, with opposition parties pressing the government for more details on the case, and the government refusing to release information citing national security and privacy concerns.
Qiu and Cheng along with several Chinese students were escorted out of NML, Canada’s only Level 4 lab, in July 2019, amid a police investigation. The two scientists were formally fired in January 2021.
The Public Health Agency of Canada (PHAC), which is in charge of NML, said the termination was the result of an “administrative matter” and “possible breaches of security protocols,” but has declined to provide further details, citing security and privacy concerns.
During her time at NML, Qiu travelled several times in an official capacity to WIV, helping train personnel on Level 4 safety. The Globe and Mail later reported that scientists at NML have been collaborating with Chinese military researchers on deadly pathogens, and that one of the Chinese military researchers worked at the high-security Winnipeg lab for a period of time.
Documents and emails released by PHAC show that the shipment of Henipah and Ebola samples was done with the permission of NML authorities.
In one of the emails sent in September 2018, David Safronetz, chief of special pathogens at PHAC, informs then-head of NML Matthew Gilmour and other lab administrators about the request from WIV for the shipment of the samples, saying “I trust the lab.”
In response, Gilmour asks about the nature of the work that will be done at the Wuhan lab, and why the lab doesn’t get the material from “other, more local labs.” He also tells Safronetz that it’s “good to know that you trust this group,” asking how NML was connected with them.
In his reply, Safronetz doesn’t specifically say what the samples will be used for in China, but notes they will only be sent once all paperwork and certification is completed. He also says the WIV is requesting the material from NML “due to collaboration” with Qiu.
He adds, “Historically, it’s also been easier to obtain material from us as opposed to US labs. I don’t think other, closer labs have the ability to ship these materials.”
Gilmour resigned from his position at NML in May 2020 and joined a UK-based bioresearch company.
MPs have asked NML management why shipment of the samples was allowed and whether they knew if China performs any Gain of Function (GoF) research at WIV. GoF research involves increasing the lethal level (virulence) or transmissibility of pathogens.
NML’s acting scientific director general Guillaume Poliquin told MPs during a parliamentary committee meeting on March 22 that the lab only sent the samples to WIV after receiving assurance that no GoF research would take place.
Conservative MP John Williamson pressed for more answers, saying the word of the state-run Chinese lab can’t be trusted as the Chinese regime “has a history of theft and lies.”
The issue of GoF research at WIV has been a point of contention in the United States between lawmakers and Dr. Anthony Fauci, NIH’s head of the National Institute of Allergy and Infectious Diseases, whose organization has funded research (through EcoHealth Alliance) on coronaviruses at the Wuhan lab. U.S. Sen. Rand Paul says published work from WIV on coronaviruses shows the lab is conducting GoF research, a charge Fauci denies.
The Epoch Times sought comment from PHAC, including as to how the agency addressed issues of intellectual property and the development of any products such as vaccines with WIV, but didn’t hear back by time of publication.
Despite repeated requests by opposition parties for more details related to the firing of the two NML scientists, the Liberal government has refused to provide records, saying there are national security and privacy concerns.
After the House of Commons issued an order for the government to disclose the information, the government took the Speaker of the House to court to obtain confirmation from a judge that it can withhold the documents. The government later dropped its court case once Prime Minister Justin Trudeau called an election and Parliament was dissolved. – Epoch Times
ALSO IN 2019, INDIA CONDUCTS NIPAH OUTBREAK DRILLS. OFFICIALS SAY THEY HOPE FOR FULL PREPAREDNESS BY 2022:
ECO-HEALTH ALLIANCE INVOLVED AGAIN!
THERE ARE SEVERAL PATENTS FOR NIPAH DRUGS AND SOME ARE mRNA GENE THERAPIES REGISTERED AS VACCINES
UPDATE 3: I FOUND CREDIBLE SOURCES FOR MOST OF DR. ARYANA LOVE’S EXPLOSIVE CLAIMS BELOW:
I didn’t have an in depth look at all her sources, I can’t have a final 100% verdict, but I did more than a glance and no lies detected. You can review her blog post yourself HERE. This might be the closure to this report and the start for another.
To be continued? Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way. We hardly made it before, but this summer something’s going on, our audience stats show bizarre patterns, we’re severely under estimates and the last savings are gone. We’re not your responsibility, but if you find enough benefits in this work… Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Article 8 of The Rome Statute of The International Criminal Court (ICC) defines biological experiments as war crimes. The US, however, is not a state party to the international treaty, and cannot be held accountable for its war crimes.
So much to take in here, no time for introductions:
The Pentagon Bioweapons
by Dilyana Gaytandzhieva
Dilyana Gaytandzhieva is a Bulgarian investigative journalist, Middle East correspondent and founder of Arms Watch. Over the last two years she has published a series of revealing reports on weapons supplies to terrorists in Syria and Iraq. Her current work is focused on documenting war crimes and illicit arms exports to war zones around the world.
Attention: for expired/deleted links, learn to use the Wayback Machine from the Internet Archive, their apps and plugins are great.
The US Army regularly produces deadly viruses, bacteria and toxins in direct violation of the UN Convention on the prohibition of Biological Weapons. Hundreds of thousands of unwitting people are systematically exposed to dangerous pathogens and other incurable diseases. Bio warfare scientists using diplomatic cover test man-made viruses at Pentagon bio laboratories in 25 countries across the world. These US bio-laboratories are funded by the Defense Threat Reduction Agency (DTRA) under a $ 2.1 billion military program– Cooperative Biological Engagement Program (CBEP), and are located in former Soviet Union countries such as Georgia and Ukraine, the Middle East, South East Asia and Africa.
Georgia as a testing ground
The Lugar Center is the Pentagon bio laboratory in Georgia. It is located just 17 km from the US Vaziani military airbase in the capital Tbilisi. Tasked with the military program are biologists from the US Army Medical Research Unit-Georgia (USAMRU-G) along with private contractors. The Bio-safety Level 3 Laboratory is accessible only to US citizens with security clearance. They are accorded diplomatic immunity under the 2002 US-Georgia Agreement on defense cooperation.
Information obtained from the US federal contracts registry clarifies some of the military activities at The Lugar Center – among them research on bio-agents (anthrax, tularemia) and viral diseases (e.g. Crimean-Congo Hemorrhagic Fever), and the collection of biological samples for future experiments.
Pentagon contractors produce bio agents under diplomatic cover
The Defense Threat Reduction Agency (DTRA) has outsourced much of the work under the military program to private companies, which are not held accountable to Congress, and which can operate more freely and move around the rule of law. US civilian personnel performing work at The Lugar Center have also been given diplomatic immunity, although they are not diplomats. Hence, private companies can perform work, under diplomatic cover, for the US government without being under the direct control of the host state – in this case the Republic of Georgia. This practice is often used by the CIA to provide cover for its agents. Three private American companies work at the US bio-laboratory in Tbilisi – CH2M Hill, Battelle and Metabiota. In addition to the Pentagon, these private contractors perform research for the CIA and various other government agencies.
CH2M Hill has been awarded $341.5 million DTRA contracts under the Pentagon’s program for bio-laboratories in Georgia, Uganda, Tanzania, Iraq, Afghanistan, South East Asia. Half of this sum ($161.1 million), being allocated to The Lugar Center, under the Georgian contract. According to CH2M Hill, the US Company has secured biological agents and employed former bio warfare scientists at The Lugar Center. These are scientists who are working for another American company involved in the military program in Georgia – Battelle Memorial Institute.
Project Clear Vision (1997 and 2000), a joint investigation by the CIA and the Battelle Memorial Institute, under a contract awarded by the Agency, reconstructed and tested a Soviet-era anthrax bomblet in order to test its dissemination characteristics. The project’s stated goal was to assess bio-agents dissemination characteristics of bomblets. The clandestine CIA-Battelle operation was omitted from the US Biological Weapons Convention declarations submitted to the UN.
Top Secret Experiments
Battelle has operated a Top Secret Bio laboratory (National Biodefense Analysis and Countermeasures Center – NBACC) at Fort Detrick, Maryland under a US Department of Homeland Security (DHS) contract for the last decade. The company has been awarded a $344.4 million federal contract (2006 – 2016) and another $17.3 million contract (2015 -2026) by DHS.
Besides the military experiments at the Lugar Center in Georgia, Battelle has already produced bioterrorism agents at the Biosafety Level 4 NBACC Top Secret Laboratory at Fort Detrick in the US. A NBACC presentation lists 16 research priorities for the lab. Amongst them to characterize classical, emerging and genetically engineered pathogens for their BTA (biological threat agent) potential; assess the nature of nontraditional, novel and non-endemic induction of disease from potential BTA and to expand aerosol-challenge testing capacity for non-human primates.
The US Company Metabiota Inc. has been awarded $18.4 million federal contracts under the Pentagon’s DTRA program in Georgia and Ukraine for scientific and technical consulting services. Metabiota services include global field-based biological threat research, pathogen discovery, outbreak response and clinical trials. Metabiota Inc. had been contracted by the Pentagon to perform work for DTRA before and during the Ebola crisis in West Africa and was awarded $3.1 million (2012-2015) for work in Sierra Leone – one of the countries at the epicenter of the Ebola outbreak.
A July 17, 2014 report drafted by the Viral Hemorrhagic Fever Consortium, accused Metabiota Inc. of failing to abide by an existing agreement on how to report test results and for bypassing the Sierra Leonean scientists working there. The report also raised the possibility that Metabiota was culturing blood cells at the lab, something the report said was dangerous, as well as misdiagnosing healthy patients. All of those allegations were denied by Metabiota.
Military Experiments on biting insects
Entomological warfare is a type of biological warfare that uses insects to transmit diseases. The Pentagon has allegedly performed such entomological tests in Georgia and Russia. In 2014 The Lugar Center was equipped with an insect facility and launched a project “Raising Awareness about Barcoding of Sand Flies in Georgia and Caucasus”. The project covered a larger geographic area outside of Georgia – Caucasus. In 2014-2015 Phlebotomine sand fly species were collected under another project “Surveillance Work on Acute Febrile Illness” and all (female) sand flies were tested to determine their infectivity rate. A third project, also including sand flies collection, studied the characteristics their salivary glands.
A biting fly in a bathroom in Tbilisi (photo 1), flies in Georgia (photo 2, 3)
As a result Tbilisi has been infested with biting flies since 2015. These biting insects live indoors, in bathrooms, all year long, which was not the typical behaviour of these species in Georgia previously (normally the Phlebotomine fly season in Georgia is exceptionally short – from June to September). Local people complain of being bitten by these newly appeared flies while naked in their bathrooms. They also have a strong resistance to cold and can survive even in the sub-zero temperatures in the mountains.
Biting Flies in Dagestan, Russia
Since the start of the Pentagon project in 2014 flies similar to those in Georgia have appeared in neighboring Dagestan (Russia). According to local people, they bite and cause rashes. Their breeding habitats are house drains.
Flies in Georgia (on the left). The same species in Dagestan (on the right)
Flies from the Phlebotomine family carry dangerous parasites in their saliva which they transmit through a bite to humans. The disease, which these flies carry, is of high interest to the Pentagon. In 2003 during the US invasion of Iraq American soldiers were severely bitten by sand flies and contracted Leishmoniasis. The disease is native to Iraq and Afghanistan and if left untreated the acute form of Leishmoniasis can be fatal.
A 1967 US Army report “Arthropods of medical importance in Asia and the European USSR” lists all local insects, their distribution and the diseases that they carry. Biting flies, which live in drains, are also listed in the document. Their natural habitats, though, are the Philippines, not Georgia or Russia.
Operation Whitecoat: Infected flies tested to bite humans
In 1970 and 1972, Sand Fly Fever tests were performed on humans according to a declassified US Army report – US Army Activities in the US, Biological Warfare Programs, 1977, vol. II, p. 203. During operation Whitecoat volunteers were exposed to bites by infected sand flies. Operation Whitecoat was a bio-defense medical research program carried out by the US Army at Fort Detrick, Maryland between 1954 and 1973.
Despite the official termination of the US bio-weapons program, in 1982 USAMRIID performed an experiment if sand flies and mosquitoes could be vectors of Rift Valley Virus, Dengue, Chikungunya and Eastern Equine Encephalitis – viruses, which the US Army researched for their potential as bio-weapons.
The Pentagon has a long history in using insects as vectors for diseases. According to a partially declassified 1981 US Army report, American bio warfare scientists carried out a number of experiments on insects. These operations were part of the US Entomological Warfare under the Program for Biological Weapons of the US.
The Pentagon: How to kill 625,000 people for just $0.29 cost per death
A US Army report in 1981 compared two scenarios – 16 simultaneous attacks on a city by A. Aegupti mosquitoes, infected with Yellow Fever, and Tularemia aerosol attack, and assesses their effectiveness in cost and casualties.
Operation Big Itch: Field tests were performed to determine coverage patterns and survivability of the tropical rat flea Xenopsylla cheopis for use as a disease vector in biological warfare.
Operation Big Buzz: 1 million A. Aeugupti mosquitoes were produced, 1/3 were placed in munitions and dropped from aircraft, or dispersed on the ground. The mosquitoes survived the airdrop and actively sought out human blood.
Operation May Day: Aedes Aegupti mosquitoes were dispersed through ground based methods in Georgia, USA, during a US Army operation codenamed May Day.
Parts of the 1981 US Army report such as the “Mass production of Aedes Aegypti” have not been declassified, potentially meaning that the project is still ongoing.
Aedes Aegypti, also known as yellow fever mosquito, have been widely used in US military operations. The same species of mosquitoes are alleged to be the vectors of dengue, chikungunya and the Zika virus, which causes genetic malformations in newborns.
The US Army Chemical Research and Development Command, Biological Weapons Branch, studied outdoor mosquito biting activity in a number of field tests at Dugway Proving Ground, Utah, in 1960. Virgin female Aedes aegypti mosquitoes, which had been starved, were tested upon troops out in the open air.
Military Experiments with Tropical Mosquitoes and Ticks in Georgia
Such species of mosquitoes and fleas (studied in the past under the US Entomological Warfare Program) have also been collected in Georgia and tested at The Lugar Center.
Under the DTRA project “Virus and Other Arboviruses in Georgia” in 2014 the never-before-seen tropical mosquito Aedes albopictus was detected for the first time and after decades (60 years) the existence of Aedes Aegypti mosquito was confirmed in West Georgia.
Aedes Aegupti Mosquitoes have been distributed only in Georgia, Southern Russia and Northern Turkey. They were detected for the first time in 2014 after the start of the Pentagon program at The Lugar Center.
Under another DTRA project “Epidemiology and Ecology of Tularemia in Georgia” (2013-2016) 6,148 ground ticks were collected ; 5,871 were collected off the cattle and 1,310 fleas and 731 ticks were caught. In 2016 a further 21 590 ticks were collected and studied at The Lugar Center.
In 2007 despite the anthrax outbreak the Georgian government terminated the compulsory vaccination for 7 years, 2013 saw NATO start human trials on a new anthrax vaccine in Georgia.
Pentagon Research on Russian Anthrax
Anthrax is one of the bio agents weaponized by the US Army in the past. Despite the Pentagon’s claims that its program is only defensive, there are facts to the contrary. In 2016 at The Lugar Center American scientists carried out research on the “Genome Sequence of the Soviet/Russian Bacillus anthracis Vaccine Strain 55-VNIIVViM”, which was funded by the U.S. Defense Threat Reduction Agency’s (DTRA) Cooperative Biological Engagement Program in Tbilisi, and administered by Metabiota (the US contractor under the Pentagon program in Georgia).
34 people infected with Crimean-Congo Hemorrhagic Fever (CCHF) in Georgia
Crimean-Congo hemorrhagic fever (CCHF) is caused by infection through a tick-borne virus (Nairovirus). The disease was first characterized in Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in Congo, thus resulting in the current name of the disease. In 2014 34 people became infected (among which a 4-year old child) with CCHF. 3 of which died. The same year Pentagon biologists studied the virus in Georgia under the DTRA project “Epidemiology of febrile illnesses caused by Dengue viruses and other Arboviruses in Georgia”. The project included tests on patients with fever symptoms and the collection of ticks, as possible vectors of CCHV for laboratory analysis.
34 people became infected with CCHF, 3 of them died in Georgia. Source: NCDC-Georgia
The cause of the CCHF outbreak in Georgia is still unknown. According to the local Veterinary Department report, only one tick from all of the collected species from the infected villages tested positive for the disease. Despite the claims of the local authorities that the virus was transmitted to humans from animals, all animal blood samples were negative too. The lack of infected ticks and animals is inexplicable given the sharp increase of CCHF human cases in 2014, meaning that the outbreak was not natural and the virus was spread intentionally.
In 2016 another 21 590 ticks were collected for DNA database for future studies at The Lugar Center under the Pentagon project “Assessing the Seroprevalence and Genetic Diversity of Crimean-Congo Hemorrhagic Fever Virus (CCHFV) and Hantaviruses in Georgia”.
Military bio-lab blamed for deadly CCHF outbreak in Afghanistan
237 cases of Crimean-Congo Hemorrhagic Fever (CCHF) have also been reported across Afghanistan, 41 of which were fatal as of December 2017. According to Afghanistan’s Ministry of Health most of the cases have been registered in the capital Kabul where 71 cases have been reported with 13 fatalities, and in the province of Herat near the border with Iran (67 cases).
Afghanistan is one of 25 countries across the world with Pentagon bio-laboratories on their territory. The project in Afghanistan is part of the US bio-defense program – Cooperative Biological Engagement Program (CBEP), which is funded by the Defense Threat Reduction Agency (DTRA). The DTRA contractors, working at The Lugar Center in Georgia, CH2M Hill and Battelle have also been contracted for the program in Afghanistan. CH2M Hill has been awarded a $10.4 million contract (2013-2017). The Pentagon contractors in Afghanistan and Georgia are the same and so are the diseases which are spreading among the local population in both countries.
Why the Pentagon collects and studies bats
Bats are allegedly the reservoir hosts to the Ebola Virus , Middle East Respiratory Syndrome (MERS) and other deadly diseases. However, the precise ways these viruses are transmitted to humans are currently unknown. Numerous studies have been performed under the DTRA Cooperative Biological Engagement Program (CBEP) in a search for deadly pathogens of military importance in bats.
Bats have been blamed for the deadly Ebola outbreak in Africa (2014-2016). However, no conclusive evidence of exactly how the virus “jumped” to humans has ever been provided, which raises suspicions of intentional and not natural infection.
Engineering deadly viruses is legal in the US
MERS-CoV is thought to originate from bats and spread directly to humans and/or camels. However, like Ebola, the precise ways the virus spreads are unknown. 1,980 cases with 699 deaths were reported in 15 countries across the world (as of June 2017) caused by MERS-CoV.
3 to 4 out of every 10 patients reported with MERS have died (Source: WHO)
MERS-CoV is one of the viruses that have been engineered by the US and studied by the Pentagon, as well as Influenza and SARS. Confirmation of this practice is Obama’s 2014 temporary ban on government funding for such “dual-use” research. The moratorium was lifted in 2017 and experiments have continued. Enhanced Potential Pandemic Pathogens (PPPs) experiments are legal in the US. Such experiments aim to increase the transmissibility and/or virulence of pathogens.
Tularemia as Bioweapon
Tularemia, also known as Rabbit Fever, is classified as a bioterrorism agent and was developed in the past as such by the US. However, the Pentagon’s research on tularemia continues, as well as on possible vectors of the bacteria such as ticks and rodents which cause the disease. The DTRA has launched a number of projects on Tularemia along with other especially dangerous pathogens in Georgia. Especially Dangerous Pathogens (EDPs), or select agents, represent a major concern for the public health globally. These highly pathogenic agents have the potential to be weaponized with proof of their military importance seen through the following Pentagon projects: Epidemiology and Ecology of Tularemia inGeorgia (2013-2016) (60 000 vectors were collected for strain isolates and genome research); Epidemiology of Human Tularemia in Georgia and Human Disease Epidemiology and Surveillance of Especially Dangerous Pathogens in Georgia (study of select agents among patients with undifferentiated fever and hemorrhagic fever/septic shock).
Tularemia is one of the bio-weapons that the US Army developed in the past. Source: 1981 US Army Report
Pentagon bio-laboratories spread diseases in Ukraine
The DoD Defense Threat Reduction Agency (DTRA) has funded 11 bio-laboratories in the former Soviet Union Country Ukraine, bordering on Russia.
The US military program is sensitive information
Ukraine has no control over the military bio-laboratories on its own territory. According to the 2005 Agreement between the US DoD and the Ministry of Health of Ukraine the Ukrainian government is prohibited from public disclosure of sensitive information about the US program and Ukraine is obliged to transfer to the US Department of Defense (DoD) dangerous pathogens for biological research. The Pentagon has been granted access to certain state secrets of Ukraine in connection with the projects under their agreement.
Biowarfare scientists under diplomatic cover
Among the set of bilateral agreements between the US and Ukraine is the establishment of the Science and Technology Center in Ukraine (STCU) – an International organization funded mainly by the US government which has been accorded diplomatic status. The STCU officially supports projects of scientists previously involved in the Soviet biological weapons program. Over the past 20 years the STCU has invested over $285 million in funding and managing some 1,850 projects of scientists who previously worked on the development of weapons of mass destruction.
364 Ukrainians died from Swine Flu
One of the Pentagon laboratories is located in Kharkiv, where in January 2016 at least 20 Ukrainian soldiers died from Flu-like virus in just two days with 200 more being hospitalized. The Ukrainian government did not report on the dead Ukrainian soldiers in Kharkiv. As of March 2016 364 deaths have been reported across Ukraine (81.3 % caused by Swine Flu A (H1N1) pdm09 – the same strain which caused the world pandemic in 2009).
According to DPR intelligence information the US bio lab in Kharkiv leaked the deadly virus.
Police investigate infection with incurable disease
A highly suspicious Hepatitis A infection spread rapidly in just few months across South East Ukraine where most of the Pentagon biolabs are located.
29 cases of Hepatitis A were reported in Kharkiv in November 2017. The virus was isolated in contaminated drinking water. One of the Pentagon bio-labs is located in Kharkiv which was blamed for the deadly Flu outbreak a year ago which claimed the lives of 364 Ukrainians.
Ukraine and Russia hit by new highly virulent cholera infection
A new highly virulent variant of the cholera agent Vibrio cholera, with a high genetic similarity to the strains reported in Ukraine, hit Moscow in 2014. According to a 2014 Russian Research Anti-Plaque Institute genetic study the cholera strain isolated in Moscow was similar to the bacteria which caused the epidemic in neighboring Ukraine.
Southern Research Institute, one of the US contractors working at the bio-laboratories in Ukraine, has projects on Cholera, as well as on Influenza and Zika – all pathogens of military importance to the Pentagon.
Along with Southern Research Institute, two other private American companies operate military bio-labs in Ukraine – Black&Veatch and Metabiota.
Black & Veatch Special Project Corp. was awarded $198.7 million DTRA contracts to build and operate bio-laboratories in Ukraine (under two 5-year contracts in 2008 and 2012 totaling $128.5 million), as well as in Germany, Azerbaijan, Cameroon, Thailand, Ethiopia, Vietnam and Armenia.
Metabiota has been awarded a $18.4 million federal contract under the program in Georgia and Ukraine. This US company was also contracted to perform work for the DTRA before and during the Ebola crisis in West Africa, the company was awarded $3.1 million (2012-2015) for work in Sierra Leone .
Southern Research Institute has been a prime subcontractor under the DTRA program in Ukraine since 2008. The company was also a prime Pentagon contractor in the past under the US Biological Weapons Program for research and development of bio-agents with 16 contracts between 1951 and 1962.
Southern Research Institute was also a subcontractor on a Pentagon program for anthrax research in 2001. The prime contractor being Advanced Biosystems, whose president at that time was Ken Alibek (a former Soviet microbiologist and biological warfare expert from Kazakhstan who defected to the US in 1992).
Ken Alibek was the First Deputy Director of Biopreparat, where he oversaw a program for biological weapon facilities and was the Soviet Union’s main expert on anthrax. After his defection to the US, he was engaged on Pentagon research projects.
$250 000 for lobbying Jeff Sessions for “research for US intelligence”
Southern Research Institute lobbied the US Congress and US Department of State hard for “issues related to research and development for US intelligence” and “defense related research and development”. The lobbying activities coincided with the start of the Pentagon projects on bio-labs in Ukraine and other former Soviet states.
Police investigate Botulism toxin poisoning in Ukraine
115 Botulism cases, with 12 deaths, were reported in Ukraine in 2016. In 2017 the Ukrainian Ministry of Health confirmed a further 90 new cases, with 8 deaths, of botulinum toxin poisoning (one of the most poisonous biological substances known). According to the local health authorities, the cause of the outbreak was food poisoning into which police launched an investigation. The Pentagon biolaboratories in Ukraine were among the prime suspects, as botulinum toxin is one of the bioterrorism agents which have already been produced at a Pentagon bioweapons facility in the US. (see below)
The Ukrainian government stopped supplying antitoxin in 2014 and no botulism vaccines in stock were available during the 2016-2017 outbreak.
Botulism is a rare and extremely dangerous illness caused by a toxin produced by the bacterium Clostridium botulinum.
1 gm of the toxin can kill as many as 1 million people
Botulinum neurotoxin poses a major bio-weapon threat because of its extreme potency, ease of production and transport. It causes muscles paralyses, respiratory failure and ultimately death if not treated immediately. A single gram of crystalline toxin, evenly dispersed and inhaled can kill more than one million people. It could be disseminated via aerosol, or by contamination of water and/ or food supplies.
The Pentagon produces live Viruses, Bacteria & Toxins
Botulinum Toxin was tested as a bio-weapon by the US Army in the past, as well as Anthrax, Brucella and Tularemia. Although the US bio-weapons program was officially terminated in 1969 documents show that the military experiments have never ended. Presently the Pentagon produces and tests live bio- agents at the same military facility as it did in the past – Dugway Proving Ground.
The US Army produces and tests bio-agents at a special military facility located at Dugway Proving Ground (West Desert Test Center, Utah), as proven in a 2012 US Army Report. The facility is overseen by the Army Test and Evaluation Command.
The Life Sciences Division (LSD) at Dugway Proving Ground is tasked with the production of bio-agents. According to the Army report, scientists from this division produce and test aerosolized bio-agents at Lothar Saloman Life Sciences Test Facility (LSTF).
The Life Sciences Division consists of an Aerosol Technology branch and a Microbiology Branch. The Aerosol Technology Branch aerosolizes biological agents and simulants. The Microbiology branch produces toxins, bacteria, viruses and agent-like organisms which are used in chamber and field testing.
The fermentation laboratories at the Life Sciences Test Facility grow bacteria in fermentors ranging from a small 2 L to a large 1500 L system. The fermentors are tailored specifically to the requirements of the microorganism that is being engineered – pH, temperature, light, pressure, and nutrient concentrations that give the microorganism optimal growth rates.
After the bio-agents are produced, the scientists challenge them at containment aerosol chambers.
Technicians disseminate live biological agents for identification sensitivity tests (photos: Dugway Proving Ground)
Aerosol experiments with Botulinum Neurotoxin and Anthrax
Documents prove that the US Army produces, possesses and tests aerosols of the most lethal toxin in the world – Botulinum Neurotoxin. In 2014 the Department of the Army purchased 100 mg of Botulinum Toxin from Metabiologics for tests at Dugway Proving Ground.
The experiments date back to 2007 when an unspecified quantity of the toxin was procured to the Department of the Army by the same company – Metabiologics. According to the 2012 West Desert Test Center Report, the military facility performs tests with Botulinum Neurotoxin Aerosol, as well as with aerosolized Anthrax, Yersinia pestis, and Venezuelan Equine Encephalitis Virus (VEE).
Outdoor field test programs at Dugway Proving Ground
US Army documents and photos show that the Pentagon has developed various dissemination methods for bioterrorism attacks including by explosives.
The US Army report lists numerous dissemination techniques including by bio-aerosol sprayers. Such sprayers called Micronair disseminators have already been developed by the US Army and tested at Dugway Proving Ground. According to the documents, they can be vehicle-mounted, or worn as a backpack, with a pump system which can be fitted to the unit to increase the accuracy of the release. Micronair sprayers can release 50 to 500 mL of bio-liquid simulant per minute from 12 L tanks.
The US stole bacteria from Saddam Hussein’s bio weapons factory
Bacillus thuringiensis is an insect pathogen that is widely used as a bio-pesticide. B. thuringiensis (BT) Al Hakam was collected in Iraq by the UN Special Commission led by the US in 2003. It is named after Al Hakam – Iraq’s bio-weapons production facility. Apart from Pentagon field tests, this bacterium is also used in the US for the production of GM corn, resistant to pests. Photos posted by the CIA prove that the bacteria was collected by the US in Iraq. According to the CIA, the vials containing bio-pesticide, were recovered from an Al Hakam scientist’s home.
Information from the US federal contracts registry shows that the Pentagon performs tests using the bacteria stolen from Saddam Hussein’s bio-weapons factory in Iraq.
The tests are performed at Kirtland Air Force Base (Kirtland is the home of the Air Force Materiel Command’s Nuclear Weapons Center). Here weapons are being tested, meaning that the field tests with biological simulants (bacteria) also fall into this group.
The DTRA contractor on this project – Lovelace Biomedical and Environmental Research Institute (LBERI), operates an Animal Bio-safety 3 Level (ABSL-3) laboratory which has Select Agent status. The facility is designed to conduct bioaerosol studies. The company has been awarded a 5-year contract for field tests with biological simulants at Kirtland Air Force Base.
Field tests with Biological Simulants (bacteria)
What the Pentagon is now doing is exactly what it did in the past, meaning that its bio-weapons program was never terminated. The US Army performed 27 field tests with such biological simulants, involving the public domain from 1949 to 1968, when President Nixon officially announced the end of the program.
The Defense Threat Reduction Agency (DTRA), which runs the US military program at the Lugar Center in Georgia, is alleged to have already performed field tests with an unknown substance in Chechnya, Russia. In the spring of 2017 local citizens reported on a drone disseminating white powder close to the Russian border with Georgia. Neither the Georgian border police, nor the US personnel operating on the Georgia-Russia border, commented on this information.
$9.2 million US military project on Russia-Georgia border
DTRA has full access to the Russia-Georgia border, granted under a military program called “Georgia Land Border Security Project”. The activities, related to the project have been outsourced to a private American company – Parsons Government Services International. DTRA has previously contracted Parsons for similar border security projects in Lebanon, Jordan, Libya and Syria. Parsons have been awarded a $9.2 million contract under the Pentagon border security project on the Russia-Georgia border.
US Defense Agency tests GM Insects to transmit GM Viruses
The Pentagon has invested at least $65 million in gene editing. The US Defense Advanced Research Projects Agency (DARPA) has awarded 7 research teams to develop tools for genome engineering in insects, rodents and bacteria under DARPA’s Safe Gene program, using a novel CRISPR-Cas9 technology.
Besides gene editing in insects and in the viruses they transmit, the Pentagon wants to engineer humans as well. DARPA Advanced Tools for Mammalian Genome Engineering Project seeks to create a biological platform inside the human body, using it to deliver new genetic information, and thus altering humans at the DNA level.
DARPA wants to insert an additional 47th artificial chromosome into human cells. This chromosome will deliver new genes that will be used for engineering the human body. SynPloid Biotek LLC has been awarded two contracts under the program totaling $1.1 million (2015-2016 – $ 100,600 for the first phase of the research; 2015-2017 – $ 999,300 for work which is not specified in the federal contracts registry. The company has only two employees and no previous record on bio-research.
Top Secret Research on Synthetic Viruses
Between 2008 and 2014, the United States invested approximately $820 million in synthetic biology research, Defense being a major contributor. Most of the military projects on synthetic biology are classified, among them are a number of classified studies by the secretive JASON group of US military advisors – e.g. Emerging Viruses and Genome Editing for the Pentagon, and Synthetic Viruses for the National Counterterrorism Center.
JASON is an independent scientific advisory group that provides consulting services to the U.S. government on matters of defense science and technology. It was established in 1960 and most of their resulting JASON reports are classified. For administrative purposes, the JASON’s projects are run by the MITRE Corporation, which has contracts with the Defense Department, CIA and the FBI. Since 2014 MITRE has been awarded some $27.4 million in contracts with the DoD.
Although the JASON Reports are classified, another US Air Force study titled Biotechnology: Genetically Engineered Pathogens, sheds some light on what the secretive JASON group has researched – 5 groups of genetically engineered pathogens that can be used as bio-weapons. These are binary biological weapons (a lethal combination of two viruses), host swapping diseases (animal viruses that “jump” to humans, like the Ebola virus), stealth viruses, and designer diseases. Designer diseases can be engineered to target a certain ethnic group, meaning that they can be used as ethnic bio-weapons.
Ethnic biological weapon (biogenetic weapon) is a theoretical weapon that aims to primarily harm people of specific ethnicities, or genotypes. Although officially the research and development of ethnic bio-weapons have never been publicly confirmed, documents show that the US collects biological material from certain ethnic groups – Russians and Chinese.
The US Air Force has been specifically collecting Russian RNA and synovial tissue samples, raising fears in Moscow of a covert US ethnic bio-weapons program.
Apart from Russians, the US has been collecting biological material from both healthy and cancer patients in China. The National Cancer Institute has collected biological samples from 300 subjects from Linxian, Zhengzhou, and Chengdu in China. While another federal project, titled Serum Metabolic biomarkers discovery study of Esophageal Squamous Cell Carcinoma in China, includes analysis of 349 serum samples which have been collected from Chinese patients.
Tobacco Vaccines: How the Pentagon helped tobacco companies to profit from Ebola
The Defense Advanced Research Projects Agency (DARPA) has invested $100 million in vaccines production from tobacco plants. The companies, involved in the project, are owned by the biggest American tobacco companies – Mediacago Inc. is co-owned by Philip Morris, and Kentucky BioProcessing is a subsidiary of Reynolds American which is owned by British American Tobacco. Currently they are producing Flu and Ebola vaccines from tobacco plants.
The $100 million program Blue Angel was launched as a response to the H1N1 pandemic in 2009. Medicago being awarded $21 million to produce 10, 000 million doses of an influenza vaccine within one month.
Blue Angel program manager Dr. John Julias explains: “Although there are multiple plant species and other organisms being explored as alternative protein production platforms, the US Government has continued to make an investment in tobacco-based manufacturing.”
The plant-based vaccine production method works by isolating a specific antigen protein that triggers a human immune response from the targeted virus. A gene from the protein is transferred to bacteria, which is used to infect plants. The plants then start producing the protein that will be used for vaccinations (photos: DARPA)
It is not clear why the Pentagon chose to invest in vaccines produced from tobacco plants amongst all other plant species, which they explored. Medicago, co-owned by Philip Morris, paid $495,000 for lobbying the Department of Defense, the Congress and The Department of Health and Human Services for “funding to advance technology to support public health preparedness applications”. The Pentagon funded tobacco companies to develop new technology and to profit from vaccines. – http://dilyana.bg/
Bulgarian journalist confronts US official over secret biolabs
On 16 January 2018, a Bulgarian investigative journalist Dilyana Gaytandzhieva wrote a detailed article about the US bio-weapons research that spans across the world in 25 different countries. Gaytandzhieva wrote in her article that the US Army regularly produces deadly viruses, bacteria and toxins in direct violation of the UN Convention on the prohibition of biological weapons, and that hundreds of thousands of unwitting people are systematically exposed to dangerous pathogens and other incurable diseases. She added that bio-warfare scientists are using diplomatic cover test man-made viruses at Pentagon bio-laboratories in 25 countries across the world. These bio-laboratories are funded by the Defense Threat Reduction Agency (DTRA) under a $2.1 billion military program called Cooperative Biological Engagement Program (CBEP), and are located in countries such as Ukraine, Kazakhstan, Uzbekistan, Georgia, Azerbaijan, Jordan, Iraq, Afghanistan, Pakistan, Laos, Cambodia, the Philippines, etc. Luckily, the Balkans seems to be clear.
Gaytandzhieva recently traveled to Brussels and attended the European Parliament in order to confront Robert Kadlec, Assistant Secretary at the US Department of Health, regarding the number of classified bio-weapons research labs scattered through Eastern Europe and Central Asia. Kadlec categorically denied the existence of an American bio-weapon program as well as that information surrounding the labs in question were classified. Gaytandzhieva attempted to continue her follow up but was silenced by Hilde Vautmans, the EU official sitting next to Kadlec, who stated “This is not an investigation” to applause from the audience and an embrace between herself and Kadlec. Gaytandzhieva didn’t stop there, however, following Kadlec to the elevator and continuing to ask him questions regarding the bio-weapons program which Kadlec refused to answer. Security staff then refused to let Gaytandzhieva on the elevator.
Here’s the full transcript of the exchange between Gaytandzhieva and Kadlec:
Gaytandzhieva: Why has the Pentagon been operating military bio-laboratories in 25 countries, bordering on the US rivals Russia, China and Iran, and why has the number of deadly outbreaks, in all those countries, increased dramatically since the start of the military program of the United States in these countries? Kadlec: I will say unequivocally and undeniably, the US does not have a military biological weapons program. Period. End of statement. Number two [interrupts Gaytandzhieva], we have been working, and I do know from the Department of Defense, they have been working with partners in parts the World, to ensure that those laboratories, and we trained them to do the diagnostic tests on these diseases, to ensure that they can manage them and also safely secure those facilities, so they’re not accessible by terrorists, or by criminals, who would do ill with them. Gaytandzhieva: Why are all these projects classified information? All these bio-laboratories of the Pentagon in 25 countries across the world? Why are they classified information? Kadlec: They’re not classified, they’re openly avaliable to anyone who wants to look at them. Gaytandzhieva: No, I tried it. No, this is not true. They are classified information. Vautmans: Ok, ok, I think I will not give you more time. We will try to answer your questions, but that’s not the place here. Case closed, thank you very much [kisses with Kadlec].
Gaytandzhieva then followed Kadlec to the elevator and continued to ask him questions regarding the bio-weapons program.
Gaytandzhieva: Just one more question? Kadlec: No more questions. Gaytandzhieva: What is the need of military biolaboratories of the United States in 25 countries across the world?
She attempted to enter the elevator, but was forcibly stopped.
Gaytandzhieva: This is public area, sorry, I can use the elevator. Security man: Sorry not this one, it’s full. Gaytandzhieva: I can use the elevator. Security man: No more questions then [trying to prevent cameraman]. Gaytandzhieva: Why not? Why is the Pentagon investing 65 million dolars in gene editing? The gene editing is the part of this program.
Elevator gates closed.
Later, Gaytandzhieva posted the video on her social media pages, simply commenting: “How a journalist gets expelled from the European Parliament when asking the Assistant Secretary at the US Department of Health questions about the Pentagon bio-laboratories around Russia, China and Iran.
Although unable to retrieve any answers from Kadlec, her article is already an impressive collection of information revealing a network of bio-weapons research facilities as well as mysterious outbreaks in their vicinities.
This is not the first time that Gaytandzhieva is exposing the US secret military programs. Last summer, she published a bombshell report which found that an Azerbaijan state airline company was regularly transporting tons of cheap Bulgarian and East European weaponry to Saudi Arabia, United Arab Emirates and Turkey, under diplomatic cover as part of the CIA covert program. These weapons were found inside underground terrorist warehouses belonging to Al Nusra Front, Al Qaeda affiliate in Syria designated as a terrorist organization by the UN. The US modus operandi was the same: using bases in the satellite countries, abuse of diplomatic channels, and dirty politics directed against Russia, Iran and Syria.
New data leak from the Pentagon biolaboratory in Georgia
By Dilyana Gaytandzhieva -September 7, 2020012011http://www.facebook.com/plugins/like.php?href=http://dilyana.bg/new-data-leak-from-the-pentagon-biolaboratory-in-georgia/&layout=button_count&show_faces=false&width=105&action=like&colorscheme=light&height=21
Leaked e-mails between the Lugar Center, the Pentagon biolaboratory in Tbilisi, the US Embassy to Georgia and the Georgian Ministry of Health reveal new information about the $161 million secretive US Government biological research program in this former Soviet country.
The data allegedly originating from the Ministry of Health of Georgia has been published anonymously on Twitter and on a forum for database leaks – Raidforums. Among the documents there are internal memos, official letters and detailed information about US government projects at the Lugar Center, funding and foreign business trips.
Arms Watch volunteers have analyzed these documents and discovered very interesting facts about the Center’s recent activities.
The Pentagon has planned to turn Georgia into its largest biological research center overseas, combining its military resources with the resources of the US Centers for Disease Control (CDC) in Georgia.
Furthermore, the number of US projects and grants have increased as well as the number of US scientists deployed to the Lugar Center. The Pentagon-funded facility is planned to temporarily accommodate 16 CDC specialists from Atlanta, for whom Georgia will build a separate BSL-2 laboratory, administrative building and a campus near the Lugar Center. In addition, Georgia will become a regional CDC hub for Eastern Europe and Central Asia, internal documents reveal.
The Lugar Center already sparked controversy about possible dual-use research in 2018 when leaked documents revealed that US diplomats in Georgia were involved in the trafficking of frozen human blood and pathogens for a secret military program.
Pentagon research on bioterrorism agents at the Lugar Center
US military scientists have been deployed to Georgia for research on bioterrorism agents at the Lugar Center, according to the new data-leak. These bio-agents have the potential to be aerosolized and used as bioweapons. Among them anthrax, tularemia, Brucella, Crimean-Congo Hemorrhagic Fever, Hantavirus, Y. pestis (causing the disease plague).
The US military biological research projects in Georgia have been funded by the Defense Threat Reduction Agency (DTRA). According to internal data, American and Georgian scientists are currently working on the following DTRA projects in the Lugar Center:
Project 1059:Zoonotic Infections with Fever and Skin Injuries in Georgia
The project includes isolation of new orthopoxviruses in humans, rodents, domestic and wild animals in Georgia, and collection of rodents (as a natural reservoir for this virus) for their further study.
Duration: 01/11/2015-31/10/2018 (extended to 2020)
Project 1060:Characterization of the Georgian National Center for Disease Control (NCDC) Strain Repository by New Generation Sequencing
Description: characterization and genome research on 100 strains from four endemic species: Y. pestis (causing the disease plague), B. anthracis (anthrax), Brucella, and F. tularensis (causing the disease tularemia).
Funding: $ 518,409
Project 1439:Molecular Virological Research in Georgia
Description and objectives:
Identify and characterize Hantavirus and Crimean-Congo hemorrhagic fever virus (CCHFV) strains by molecular methods;
Characterize and study genetic diversity of Crimean-Congo hemorrhagic fever virus and hantavirus strains isolated from rodents and ectoparasites;
Serological examination of febrile patients with Crimean-Congo hemorrhagic fever and hemorrhagic fever with renal syndrome;
Collection of rodents and ectoparasites (ticks, fleas);
Project 1497:Molecular Epidemiology and Ecology of Yersinia Species in Georgia and Azerbaijan
Description: 1) Ecological research on rodents in Kerb on the Georgian-Azerbaijani border 2) Isolation of different strains of Yersinia; 3) Molecular screening of collected rodent and flea samples. 4) A comparative analysis of the genomes of Yersinia strains obtained during the fieldwork; 5) Spatial analysis of the distribution of Yersinia strains.
Duration: 01/09/2017-31/08/2018 (extended to 2022)
Funding: $134,090.00DTRA Projects in Georgia1 of 8
Project 1742:Risks of bat-borne zoonotic diseases in Western Asia
The project’s objectives are: 1. Capture and non-lethally sample 5,000 bats in 5-year period (2017-2022) 2. Collect 20,000 samples (i.e. oral, rectal swabs and/or feces, and blood) and screen for coronaviruses using consensus PCR at regional labs in Georgia and Jordan. According to the project presentation, Eco Health Alliance already sampled 270 bats of 9 species in three Western Asian countries: 90 individual bats in Turkey (Aug 2018), Georgia (Sept 2018), and Jordan (Oct 2018).Video Player00:0003:02
EcoHealth Alliance and Georgian scientists sampling a bat for coronavirus research in 2018 (Facebook, Keti Sidamonidze)
Coincidentally, the same Pentagon contractor tasked with the US DoD bat-research program – Eco Health Alliance, USA, also collected bats and isolated coronaviruses along with Chinese scientists at the Wuhan Institute of Virology. EcoHealth Alliance received a $3.7 million grant from the US National Institutes of Health (NIH) to collect and study coronaviruses in bats in China from 2014 to 2019.
Project 1911:Ricketsia and Coxelia infection surveillance in Georgia and Azerbaijan (US federal grant HDTRA1-19-1-0042 awarded to NCDC-Georgia)
Duration: 23/09/2019 – 22/09/2022
Despite the official claims of Georgia and USA that the Lugar Center is under the full control of the government of this Caucasus country internal documents show otherwise. Not only has the Pentagon funded biological research projects but it has also paid all the expenses for security and maintenance including utility bills – water, gas, electricity, and cleaning. Tasked with the operational and scientific support to the Lugar Center is USAMRU-Georgia, a special unit deployed to Georgia by the Walter Reed Army Institute of Research (WRAIR). WRAIR has paid: $524,625 (2016-2018), $650,000 (2017-2019) and $1,062,400 (2017-2021) for utility bills, and a further $158,050 (2016-2017) and $322,000 (2018-2021) for security guards.
The Pentagon has also awarded a private US contractor, Technology Management Company (TMC) an $8 million contract for science services to support USAMRU-Georgia in the Lugar Center (2016-2021).WRAIR Projects at the Lugar Center1 of 5
Tularemia research on soldiers
The Pentagon unit USAMRU-Georgia has conducted extensive research on tularemia involving Georgian soldiers, scientific papers reveal.
Tularemia is a rare infectious disease that typically attacks the skin, eyes, lymph nodes and lungs. Tularemia, also called rabbit fever or deer fly fever, is caused by the bacterium Francisella tularensis. It is categorized as a category A bioterrorism agent. Tularemia was weaponized for mass aerosol dissemination by the US Army in the past, according to a recently declassified military report.
Tularemia is one of the bio-weapons that the US Army developed in the past. Source: 1981 US Army Report
900 volunteers (soldiers and civilians) were recruited for the DTRA project GG-19 “Epidemiology and Ecology of Tularemia in Georgia” from 2014 to 2017. Blood samples were collected from those volunteers and tested for tularemia.
According to the study, 10 soldiers (2%) of the 500 solders tested had antibodies for F. tularensis. The seropositive soldiers were men, the majority of whom were between 30 and 39 years of age. Seven cases had current residences in known endemic areas (i.e. Kakheti, Samtskhe-Javakheti, Kvemo Kartli, Shida Kartli, and Tbilisi). Three were from areas without previously known F. tularensis transmission (i.e. Imereti).
Of the 783 residents approached to participate in this study, 35 (5.0%) volunteers had antibodies to F. tularensis.
While the civilian volunteers were all residents of two areas with naturally occurring foci of tularemia in Georgia, the military personnel were soldiers visiting Georgia’s military hospital. The study does not provide any explanation as to why soldiers were enrolled in this project nor how exactly they contracted the disease in the army.Project GG-19: Tularemia in Georgia1 of 8
Furthermore, Georgia has asked the US Embassy for assistance for the construction of a second military hospital in the country, according to leaked correspondence between local health officials and the US Embassy to Tbilisi.
Below is Google translation in English of this correspondence:
CDC regional hub
The US Government has launched a parallel civil program in Georgia implemented by the US Centers for Disease Control (CDC). Leaked e-mails between the US Embassy to Tbilisi and Georgian health officials reveal that CDC has planned to set up a regional office for Eastern Europe and Central Asia in Georgia. The US Embassy and CDC have requested additional office space for 16 employees. Currently the CDC staff are working inside the Lugar Center.CDC regional hub for Eastern Europe and Central Asia in Georgia1 of 4
Interestingly, the Georgian health officials do not ask about any further information or clarification as to what this new foreign hub is going to do in their own country. Instead, Georgia’s Ministry of Health has planned the construction of a new BSL-2 laboratory, conference hall and campus near the Lugar Center with a loan from the European Investment Bank, according to a letter to the finance minister of Georgia leaked on Raidforums.
Arms Watch could not independently verify the authenticity of this letter as we did not find it in the leaked files. We have further analyzed the ministry’s internal data and discovered the following CDC projects in Georgia:
Project 1320: Antimicrobial Resistance Project
Duration: 01/09/2016 -29/09/2020
Project 1440:Introducing or Expanding the Use of Influenza Vaccine Outside the United States
Duration: 30/09/2016 – 29/09/2019
Project 1441:Influenza Surveillance Outside the United States
Duration: 30/09 / 16-29 / 09/21
Project 1446: Strengthening New Generation Sequencing Capacities for Hepatitis C Surveillance in Georgia
Duration: 01/07/2017-30 /06/2018
Project 1447:Samples collection under the Hepatitis C Elimination Program in Georgia – Bio-Bank
Objective: The aim of the project is to store samples collected under the Hepatitis C program for future scientific work
20,000 plasma/serum samples
6,000 serum samples from the 2015 National Seroprevalence Survey of Hepatitis C and B
1,000 blood samples from blood banks
500 blood samples from patients with terminal liver disease
Project 1456:Strengthening the micronutrient deficit monitoring system in Georgia
Duration: 01/09/2017 – 31/08/2018
Project 1457:Genetic peculiarities of hepatitis C virus in Georgia and its role in the Georgian Hepatitis C elimination program
Objective: Evaluate morbidity and mortality associated with Hepatitis C virus
Project 1532:Strengthening, detection, response and prevention of diarrhea outbreaks in Georgia
Duration: 30/09/2017 -29/09/2020
Project 1533:Strengthening Immunization and Vaccination Control System
Duration: 30/09/2017 – 29/09/2020
Project 1534: Respiratory Disease Surveillance
Duration: 30/09/2017 – 29/09/2020
Project 1535:Enterovirus surveillance Georgia
Duration: 30/09/2017 -29/ 09/2020
Project 1536:National Laboratory Quality Control Program in Georgia
Duration: 30/09/2017 -29 /09/2020
Project 1537:South Caucasus Field Epidemiology and Laboratory Training Program
Duration: 30/09/2017 -29 /09/2020
Project 1538: Fever of unknown etiology caused by arboviruses in the Black Sea region – clinical specimens will be shipped to the CDC Laboratory for analyses
Duration: 30/09/2017 – 29/09/2020
Funding: $100,360CDC Projects in Georgia1 of 15
In conclusion, the United States has been consistently developing its laboratory facilities in the Caucasus. Why has the US Government spent billions of dollars on such biolaboratories and projects abroad instead on the health of its own citizens?Scientists with diplomatic immunity1 of 6
Furthermore, why have US scientists working at the Lugar Center been given diplomatic status and immunity to research deadly pathogens and insects in Georgia? Diplomatic immunity is a principle of international law by which foreign government officials are not subject to the jurisdiction of local courts and other authorities for their activities. Hence, US scientists could even perform illegal experiments in Georgia without being prosecuted as they have diplomatic immunity.
All research at a Fort Detrick laboratory that handles high-level disease-causing material, such as Ebola, is on hold indefinitely after the Centers for Disease Control and Prevention found the organization failed to meet biosafety standards.
No infectious pathogens, or disease-causing material, have been found outside authorized areas at the U.S. Army Medical Research Institute of Infectious Diseases.
The CDC inspected the military research institute in June and inspectors found several areas of concern in standard operating procedures, which are in place to protect workers in biosafety level 3 and 4 laboratories, spokeswoman Caree Vander Linden confirmed in an email Friday.
The CDC sent a cease and desist order in July.
After USAMRIID received the order from the CDC, its registration with the Federal Select Agent Program, which oversees disease-causing material use and possession, was suspended. That suspension effectively halted all biological select agents and toxin research at USAMRIID, Vander Linden said in her email.
The Federal Select Agent Program does not comment on whether a program such as USAMRIID is registered and cannot comment on action taken to enforce regulations, Kathryn Harben, a spokeswoman for the CDC, wrote in an email.
“As situations warrant, [Federal Select Agent Program] will take whatever appropriate action is necessary to resolve any departures from regulatory compliance in order to help ensure the safety and security of work with select agents and toxins,” Harben said in the email.
The suspension was due to multiple causes, including failure to follow local procedures and a lack of periodic recertification training for workers in the biocontainment laboratories, according to Vander Linden. The wastewater decontamination system also failed to meet standards set by the Federal Select Agent Program, Vander Linden said in a follow-up email.
“To maximize the safety of our employees, there are multiple layers of protective equipment and validated processes,” she said.
Vander Linden could not say when the laboratory would be able to continue research.
“USAMRIID will return to fully operational status upon meeting benchmark requirements for biosafety,” she said in an email. “We will resume operations when the Army and the CDC are satisfied that USAMRIID can safely and consistently meet all standards.”
USAMRIID has been working on modified biosafety level 3 procedures and a new decontamination system since flooding in May 2018. This “increased the operational complexity of bio-containment laboratory research activities within the Institute,” she said.
At the time of the cease and desist order, USAMRIID scientists were working with agents known to cause tularemia, also called deer fly or rabbit fever, the plague and Venezuelan equine encephalitis, all of which were worked on in a biosafety level 3 laboratory. Researchers were also working with the Ebola virus in a biosafety level 4 lab, Vander Linden said.
Of the pathogens, Ebola, bacteria Yersinia pestis (plague), and bacterium Francisella tularensis (tularemia) are on the list of the Health and Human Services select agents and toxins. The three are considered Tier 1 agents, which pose a severe public health and safety threat.
Venezuelan equine encephalitis also falls under the Federal Select Agent Program, according to the Code of Federal Regulations.
The military research institute is looking at each of its contracts to see what will be affected by the shutdown. USARMIID work outside the lab is not expected to be affected, including on Ebola, Vander Linden said.
“We are coordinating closely with the CDC to ensure that critical, ongoing studies within bio-containment laboratories are completed under appropriate oversight and that research animals will continue to be cared for in accordance with all regulations,” she said in an email. “Although much of USAMRIID’s research is currently on hold, the Institute will continue its critical clinical diagnostic mission and will still be able to provide medical and subject matter expertise as needed to support the response to an infectious disease threat or other contingency.”
According to the Code of Federal Regulations, which also lists required training, records and biosafety plans, Federal Select Agents Program registration can be suspended to protect public health and safety. It is not clear if this is why the USAMRIID registration was suspended.
The code also gives the Department of Health and Human Services, under which the CDC falls, the right to inspect any site and records, without prior notifications. Vander Linden said in the email that the CDC inspected USAMRIID several times over the past year, both unannounced and on a regularly scheduled basis.
USAMRIID will work to meet requirements set by the Army and the CDC and have its suspension lifted, Vander Linden said.
“While the Institute’s research mission is critical, the safety of the workforce and community is paramount,” she said. “USAMRIID is taking the opportunity to correct deficiencies, build upon strengths, and create a stronger and safer foundation for the future.”
And I could go on like this forever, but there’s also a thing called “sufficiency”.
To be continued? Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way. We hardly made it before, but this summer something’s going on, our audience stats show bizarre patterns, we’re severely under estimates and the last savings are gone. We’re not your responsibility, but if you find enough benefits in this work… Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them